IRVINE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today provided a positive update on its substantial progress toward ...

The incorporation of real-world data from HealthVerity Marketplace will further strengthen Recursion's ability to predict patient responses, refine study designs, and ensure clinical trial sites ...

Hear from industry leaders who will dive into the growing challenges of clinical trial enrollment, highlighting the multifaceted barriers that span from regulatory constraints to the critical need ...

Participants in the ADAPT-2 clinical trial who received a combination of injectable naltrexone plus extended-release oral bupropion (NTX+BUPN) had a 27% increase in methamphetamine-negative urine ...

Additionally, Research and Markets predicted in a second new report that the global clinical trial site network market will grow at a similar rate between 2025 and 2030, hitting $13.76 billion ...

Anixa is developing the vaccine, which is entering phase two of a clinical trial at the Cleveland Clinic. According to the American Cancer Society facts and figures for 2024-2025, approximately 1 ...

A world-first clinical trial for a fridge-free vaccine has been launched in the UK which could greatly increase access to jabs in the future. The firm behind a vaccine that is completely stable at ...